CURE’s pancreatic cancer page features the latest cancer news and updates on pancreatic cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in pancreatic cancer.
January 18th 2023
The COVALENT-102 trial will investigate BMF-219 in patients with non-small cell lung cancer, colorectal and pancreatic cancers.
January 3rd 2023
Surviving cancer was tougher than my hardest days in the military. Here are some things I learned along the way.
January 2nd 2023
The targeted therapy appeared to be safe and effective in treating patients with KRAS G12C mutated pancreatic cancer, according to results from a recent study.
December 2nd 2022
The combination of pelareorep, Tecentriq, gemcitabine and Abraxane was granted FDA fast-track designation after demonstrating a 69% objective response rate in patients with advanced/metastatic pancreatic ductal adenocarcinoma.
November 29th 2022
Cancer made me realize that there is more to life than just work.
November 18th 2022
From “Star Trek” actors supporting the Pancreatic Cancer Action Network to Michelle Obama meeting with a sarcoma survivor and an update on Jane Fonda’s cancer, here’s what’s happening in the cancer space this week.
November 12th 2022
As a pancreatic cancer survivor, I realized how important it is to help others who are in the throes of their cancer experience.
October 28th 2022
From the death of “Schitt’s Creek” Emmy winning-producer “Ben Feigin” to “Good Charlotte” signer Joel Madden donating nearly $200,000 to an osteosarcoma nonprofit, here’s what’s happening in the cancer space this week.
September 27th 2022
The novel drug PY159 will be studied as a single agent and in combination with Keytruda for patients with certain solid tumors — including ovarian, pancreatic, lung, head and neck, colorectal and breast cancers.
August 25th 2022
Receiving a pancreatic cancer diagnosis has caused me to reexamine my spirituality, which led me to believe that my life is a line, rather than a single dot in time.
July 21st 2022
Treatment with FOLFIRINOX, a combination of several chemotherapy agents, prior to the surgical resection of pancreatic cancer increased survival outcomes when compared to historical data.
July 15th 2022
The first patient enrolled onto a phase 1 trial has received TCMB07, an investigational drug, for the treatment of cachexia, a severe disorder that may occur in more than half of patients with advanced-stage cancer.
July 13th 2022
The use of a chemotherapy-free, combination regimen as a maintenance treatment option was associated with an improvement in survival in a group of patients with advanced pancreatic cancer.
July 7th 2022
According to the manufacturer, this is the first-in-human clinical trial of Allocetra combined with chemotherapy in patients with peritoneal metastases arising from solid cancers.
June 3rd 2022
The addition of nimotuzumab to a treatment regimen of the chemotherapy gemcitabine improved overall survival in patients with KRAS wild-type advanced pancreatic cancer.
May 16th 2022
As I go in for another cancer follow-up, I need to remind myself that what could happen is different from what would happen.
March 16th 2022
Four sites across the United States are enrolling patients with locally advanced or metastatic pancreatic cancer to see if a novel drug combined with standard-of-care chemotherapy bests chemotherapy alone in survival outcomes and responses to treatment.
March 4th 2022
The study authors plan to enroll 32 patients with advanced pancreatic cancer into the trial to assess the efficacy and safety of an experimental treatment combination.
January 26th 2022
Single-agent adagrasib was associated with encouraging treatment responses in patients with previously treated non-colorectal gastrointestinal tumors and pancreatic ductal adenocarcinoma.
January 21st 2022
Researchers plan to enroll 60 patients in the first-in-human phase 1 clinical trial to assess the safety and preliminary clinical activity of an anti-CD39 monoclonal antibody to treat advanced solid tumors.
November 11th 2021
This study is the first to evaluate this rising trend of pancreatic cancer incidence in women under the age of 55.
October 31st 2021
A pancreatic cancer survivor explains why he chose to undergo genetic testing and what he learned from the experience.
October 29th 2021
Study results showed that CPI-613 did not improve survival in patients with metastatic adenocarcinoma of the pancreas.
October 22nd 2021
Celsion GmbH has initiated a phase 1 trial to analyze ThermoDox with focused ultrasound for patients with pancreatic cancer.
October 22nd 2021
A cancer survivor shares how to appreciate the good moments and lean on others during cancer. “My dire situation brought out the best of those around me,” he writes.
October 7th 2021
There’s a tremendous amount of interest in immunotherapy drugs given alongside targeted therapies for patients with pancreatic cancer, according to an expert.
September 24th 2021
From “Sex and the City” star and “real-life Tarzan” dying to a man planning to swim the English Channel to raise cancer funds, here is what is happening in the cancer space this week.
September 14th 2021
GC4419 plus radiation improved progression-free survival and time to distant metastases in patients with unresectable or borderline resectable locally advanced pancreatic cancer.
August 27th 2021
Cancer survivors share a unique connection. In this post, a survivor writes about meeting a stranger with stage 4 cancer who had an incredible impact on him.